These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35891260)

  • 21. Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China.
    Tung TH; Lin XQ; Chen Y; Zhang MX; Zhu JS
    Expert Rev Vaccines; 2022 Feb; 21(2):261-267. PubMed ID: 34894991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Willingness to accept COVID-19 vaccination among people living with HIV in a high HIV prevalence community.
    Govere-Hwenje S; Jarolimova J; Yan J; Khumalo A; Zondi G; Ngcobo M; Wara NJ; Zionts D; Bogart LM; Parker RA; Bassett IV
    BMC Public Health; 2022 Jun; 22(1):1239. PubMed ID: 35733209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What Is the Willingness to Receive Vaccination Against COVID-19 Among the Elderly in Italy? Data From the PASSI d'Argento Surveillance System.
    Contoli B; Possenti V; Minardi V; Binkin NJ; Ramigni M; Carrozzi G; Masocco M
    Front Public Health; 2021; 9():736976. PubMed ID: 34805065
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees.
    Attia S; Mausbach K; Klugar M; Howaldt HP; Riad A
    Front Public Health; 2022; 10():846861. PubMed ID: 35462827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 Booster Dose Coverage and Hesitancy among Older Adults in an Urban Slum and Resettlement Colony in Delhi, India.
    Sharma N; Basu S; Lalwani H; Rao S; Malik M; Garg S; Shrivastava R; Singh MM
    Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global disparities in COVID-19 vaccine booster dose (VBD) acceptance and hesitancy: An updated narrative review.
    Roy DN; Ferdiousi N; Mohabbot Hossen M; Islam E; Shah Azam M
    Vaccine X; 2024 Jun; 18():100480. PubMed ID: 38585380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy.
    Dick A; Rosenbloom JI; Karavani G; Gutman-Ido E; Lessans N; Chill HH
    Am J Obstet Gynecol MFM; 2022 Jul; 4(4):100637. PubMed ID: 35398583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
    JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between Risk Perception and Acceptance for a Booster Dose of COVID-19 Vaccine to Children Among Child Caregivers in China.
    Qin C; Wang R; Tao L; Liu M; Liu J
    Front Public Health; 2022; 10():834572. PubMed ID: 35372197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uptake of COVID-19 Vaccines among Pregnant Women: A Systematic Review and Meta-Analysis.
    Galanis P; Vraka I; Siskou O; Konstantakopoulou O; Katsiroumpa A; Kaitelidou D
    Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A positive update on COVID-19 booster vaccine willingness among Danes.
    Sønderskov KM; Vistisen HT; Dinesen PT; Østergaard SD
    Dan Med J; 2022 Jan; 69(2):. PubMed ID: 35088699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
    Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
    Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attitudes of Poles towards the COVID-19 Vaccine Booster Dose: An Online Survey in Poland.
    Babicki M; Mastalerz-Migas A
    Vaccines (Basel); 2022 Jan; 10(1):. PubMed ID: 35062729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Analysis of the Willingness to the COVID-19 Vaccine Booster Shots among Urban Employees: Evidence from a Megacity H in Eastern China.
    Hu T; Li L; Lin C; Yang Z; Chow C; Lu Z; You C
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic Review.
    Limbu YB; Huhmann BA
    Trop Med Infect Dis; 2023 Mar; 8(3):. PubMed ID: 36977160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study.
    Shehab M; Alrashed F; Alfadhli A
    Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 35893815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Willingness of the General Public to Receive A COVID-19 Vaccine Booster - China, April-May 2021.
    Wang X; Liu L; Pei M; Li X; Li N
    China CDC Wkly; 2022 Jan; 4(4):66-70. PubMed ID: 35186370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Willingness to accept COVID-19 vaccination among people living with HIV in a high HIV prevalence community.
    Govere-Hwenje S; Jarolimova J; Yan J; Khumalo A; Zondi G; Ngcobo M; Wara NJ; Zionts D; Bogart LM; Parker RA; Bassett IV
    Res Sq; 2022 Apr; ():. PubMed ID: 35441173
    [No Abstract]   [Full Text] [Related]  

  • 40. Awareness and Acceptance for COVID-19 Booster Dose Vaccination among Residents of Saudi Arabia: Findings of a Cross-Sectional Study.
    Ahmad MS; Almuteri TD; Alharbi AOM; Tawakul A; Alturiqy MAM; Alzahrani M; Almutairi SB; Almutairi GM; Alotaibi AS; Almutairi NS; Alhabdan LK; Alghuyaythat WKZ
    Vaccines (Basel); 2023 May; 11(5):. PubMed ID: 37243033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.